Loading…
Clearmind Medicine Inc. is projected to rise to $3.36 by 2027, a +35% move from its current price of $2.48. CMND is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.26 | $2.48 | $2.72 | +0.05% |
| May 30 | $2.18 | $2.48 | $2.83 | +0.11% |
| May 31 | $2.12 | $2.48 | $2.92 | +0.16% |
| Jun 1 | $2.06 | $2.49 | $2.99 | +0.21% |
| Jun 2 | $2.02 | $2.49 | $3.06 | +0.27% |
| Jun 3 | $1.98 | $2.49 | $3.12 | +0.32% |
| Jun 4 | $1.95 | $2.49 | $3.18 | +0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.95 | $2.49 | $3.18 | +0.37% |
| Week 2 | $1.77 | $2.50 | $3.54 | +0.74% |
| Week 3 | $1.64 | $2.51 | $3.84 | +1.12% |
| Week 4 | $1.54 | $2.52 | $4.11 | +1.49% |
| Week 5 | $1.46 | $2.53 | $4.37 | +1.87% |
| Week 6 | $1.39 | $2.54 | $4.63 | +2.25% |
| Week 7 | $1.33 | $2.55 | $4.87 | +2.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Clearmind Medicine Inc. is a clinical stage pharmaceutical company that develops novel psychedelic medicines to treat under-served health problems. The company focuses on treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression.
Its MEAI compound is developed for the treatment of alcohol use disorder, obesity, and metabolic disorders, and it also has an alcohol substitute consumer product; CM-CMND-001 is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. The company has strategic collaborations with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc.
The entity was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. It was incorporated in 2017 and is headquartered in Vancouver, Canada.
CMND is the stock ticker for Clearmind Medicine Inc., a healthcare company trading at $2.48 per share with a current market capitalization of $2.53M and a rank of 5384 by size.
The current price sits at $2.48, with a clearly defined forecast horizon that envisages a gradual rise in average prices through 2030 and beyond, reaching an average of $6.73 by 2050, with notable bullish periods in several intermediate years.
The multi-year forecast shows rising averages from 2026 onward (2026 avg $2.48) to 2030 ($3.67 avg) and continuing higher to 2040 ($6.37 avg) and 2050 ($6.73 avg), with corresponding ROIs up to 171.3% in 2050. Sentiment toggles across years, but remains predominantly Bullish in the later years while Neutral in select years.
A major floor 8.9% below — a decisive break under it would weaken the trend.
The nearest floor, 8.9% below — buyers have tended to step in here.
The nearest ceiling, 359.7% above — a clean break opens room to run.
A major ceiling 1004.8% above — clearing it would confirm fresh momentum.
Key CMND support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CMND market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.46 | Buy | $2.67 | Sell |
| MA 10 | $3.42 | Sell | $3.33 | Sell |
| MA 20 | $4.75 | Sell | $4.58 | Sell |
| MA 50 | $7.34 | Sell | $9.22 | Sell |
| MA 100 | $12.27 | Sell | $37.63 | Sell |
| MA 200 | $143.95 | Sell | $146.20 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 29.90 | Buy |
| Stoch RSI (14) | 26.17 | Neutral |
| CCI (20) | -102.39 | Sell |
| Williams %R (14) | -93.47 | Info |
| MACD (12,26,9) | -0.13 | Sell |
| ROC (12) | -54.99 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 6.53 | Buy |
| TRIX (15) | -2.81 | Sell |
| Awesome (5,34) | -4.14 | Sell |
| Ultimate (7,14,28) | 17.23 | Buy |
| Momentum (10) | -2.92 | Sell |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 2.03 | Buy |
| ADX (14) | 30.41 | Sell |
| ATR (14) | 0.54 | Info |
Near-term sentiment is NEUTRAL, with RSI(14) at 30.
The stock trades within a 30-day range of $1.35 to $4.57, and shows a support level at $2.26 and a resistance around $11.40. The SMA50 stands at $7.34, while the SMA200 sits at $143.95, highlighting substantial distance from long-term averages and a near-term price backdrop consistent with a cautious stance.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.26 | $2.48 | $3.23 | 0% | Neutral | |
| $2.41 | $3.36 | $5.05 | +35% | Bullish | |
| $2.55 | $3.77 | $6.02 | +52% | Bullish | |
| $2.32 | $3.60 | $6.03 | +45% | Bullish | |
| $2.26 | $3.67 | $6.40 | +48% | Bullish | |
| $1.70 | $2.89 | $5.22 | +17% | Neutral | |
| $1.61 | $2.86 | $5.32 | +15% | Neutral | |
| $2.24 | $4.13 | $7.88 | +66% | Bullish | |
| $2.48 | $4.76 | $9.33 | +92% | Bullish | |
| $2.31 | $4.62 | $9.25 | +86% | Bullish | |
| $2.87 | $6.37 | $14.01 | +157% | Bullish | |
| $3.03 | $6.73 | $15.48 | +171% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.26 | $2.48 | $2.92 | +0.00% |
| June 2026 | $2.10 | $2.51 | $3.12 | +1.34% |
| July 2026 | $2.13 | $2.60 | $3.32 | +3.56% |
| August 2026 | $1.97 | $2.43 | $3.16 | -6.58% |
| September 2026 | $1.92 | $2.39 | $3.16 | -1.55% |
| October 2026 | $2.06 | $2.60 | $3.49 | +8.80% |
| November 2026 | $2.03 | $2.59 | $3.50 | -0.68% |
| December 2026 | $1.83 | $2.36 | $3.23 | -8.86% |
Click any year to see its month-by-month CMND forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CMND is projected to trade between $2.26 and $3.23, averaging $2.48 — a potential gain of 0% from today's $2.48. A consolidation phase looks the most probable path here.
Clearmind Medicine Inc.'s 2027 outlook centres on $3.36, within a $2.41 to $5.05 range. That is up +35% on the projected 2026 average. That marks a +35% change versus current levels. Momentum favours further upside here.
By 2028, CMND could reach as high as $6.02, with a base case around $3.77 and support toward $2.55 — roughly +52% from $2.48. Buyers look set to stay in control over this stretch.
Expect CMND to range from $2.32 to $6.03 through 2029. The $3.60 average target implies a +45% move from current prices. That is -5% versus the projected 2028 average. Momentum favours further upside here.
The CMND price prediction for 2030 points to an average of $3.67 (low $2.26, high $6.40) — a potential gain of +48% on today's $2.48. Buyers look set to stay in control over this stretch.
In 2031, CMND is projected to trade between $1.70 and $5.22, averaging $2.89 — a potential gain of +17% from today's $2.48. That is -21% versus the projected 2030 average. Price action looks broadly range-bound.
Clearmind Medicine Inc.'s 2032 outlook centres on $2.86, within a $1.61 to $5.32 range. That is -1% versus the projected 2031 average. That marks a +15% change versus current levels. A consolidation phase looks the most probable path here.
By 2033, CMND could reach as high as $7.88, with a base case around $4.13 and support toward $2.24 — roughly +66% from $2.48. Momentum favours further upside here.
Expect CMND to range from $2.48 to $9.33 through 2034. The $4.76 average target implies a +92% move from current prices. That is up +15% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CMND price prediction for 2035 points to an average of $4.62 (low $2.31, high $9.25) — a potential gain of +86% on today's $2.48. Momentum favours further upside here.
In 2040, CMND is projected to trade between $2.87 and $14.01, averaging $6.37 — a potential gain of +157% from today's $2.48. That is up +38% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Clearmind Medicine Inc.'s 2050 outlook centres on $6.73, within a $3.03 to $15.48 range. That is up +6% on the projected 2040 average. That marks a +171% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CMND today (≈ 403.225806 CMND) could be worth
$2,713.18
+$1,713.18 (+171%) by 2050 · US Dollar
Based on the average projected CMND price of $6.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CMNDwould be worth at today's price.
$1,000 invested in CMND on May 27, 2025 (≈ 2.57732 CMND) would be worth
$6.39
-$993.61 (-99.4%) today · 0.01× · US Dollar
Based on a CMND entry price of $388 vs. today's $2.48.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.52 | $984.13 | -1.6% |
| 1 month ago | $7.3 | $339.73 | -66.0% |
| 3 months ago | $11.5 | $215.65 | -78.4% |
| 6 months ago | $62 | $40 | -96.0% |
| 1 year ago | $388 | $6.39 | -99.4% |
| All time (3.5y) ago | $70,800 | $0.04 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CMND forecast.
Our base-case forecast reaches $5.00 around 2040.
Implied market cap at $5.00: $5.1M
The year-by-year forecast shows a progressive path with rising averages and positive returns in several years. For 2026 the average price is $2.48 with a 0% ROI and Neutral sentiment, followed by gains in 2027 (avg $3.36, ROI 35.3%, Bullish) and 2028 (avg $3.77, ROI 51.9%, Bullish).
In 2029 the average price is $3.60 (ROI 45%, Bullish) and in 2030 an average of $3.67 (ROI 47.9%, Bullish). After a Neutral 2031 ($2.89 avg) and Neutral 2032 ($2.86 avg), 2033 shows a stronger move (avg $4.13, ROI 66.4%, Bullish), followed by 2034 (avg $4.76, ROI 92.1%, Bullish) and 2035 (avg $4.62, ROI 86.1%, Bullish).
The forecast accelerates into the 2040s, with 2040 averaging $6.37 and RO I 156.9% (Bullish), and 2050 averaging $6.73 with ROI 171.3% (Bullish). These are estimates, not guarantees, and reflect market conditions and model assumptions at the time of forecast. Risks include volatility and milestone dependence given the small-cap profile and clinical-stage nature of the asset.
Tap a question to reveal the answer.
2030: min $2.26, avg $3.67, max $6.40; ROI 47.9%; sentiment BULLISH.
Forecasts show rising averages over time with 2027 avg $3.36 (ROI 35.3%), 2028 avg $3.77 (ROI 51.9%), 2040 avg $6.37 (ROI 156.9%), and 2050 avg $6.73 (ROI 171.3%), with Bullish sentiment in those years. These are estimates, not guarantees.
Yes, according to max-price forecasts, 2034 max $9.33 and 2035 max $9.25; 2040 max $14.01 and 2050 max $15.48, indicating possible moves above $10 in later years.
Sentiment is NEUTRAL. RSI(14) is 30. The 30-day range is $1.35-$4.57, with a support at $2.26 and a resistance at $11.40. SMA50 is $7.34 and SMA200 is $143.95.
2040: avg $6.37, max $14.01, ROI 156.9%, sentiment BULLISH. 2050: avg $6.73, max $15.48, ROI 171.3%, sentiment BULLISH.
Clearmind Medicine Inc. Community Discussion
0Share your Clearmind Medicine Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.